• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Resveratrol may treat some cancer better than chemotherapy

Article

Madison, Wis. -Resveratrol may be more effective than chemotherapy in treating five cancers, and may have anti-aging effects as well as prevent heart disease, associatedcontent.com reports.

Madison, Wis.

- Resveratrol may be more effective than chemotherapy in treating five cancers, and may have anti-aging effects as well as prevent heart disease, associatedcontent.com reports.

According to the

Capital Times

, resveratrol has been shown in mice to shrink tumors and kill malignant cancer cells without harming healthy cells in skin melanoma, breast cancer, neuroblastoma, ocular melanoma and retinal blastoma.

Researchers have been studying resveratrol’s treatment potential for cancers for five years, and recently applied for permission to use resveratrol in treating babies and children with neuroblastoma, associatedcontent.com reports.

Related Videos
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Video 2 - "Optimizing Long-Term Care: Physician Insights on Secondary Dermatitis Management" - 2 KOLs in this video.
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Video 4 - "Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing Care " - 1 KOL in this panel
Video 3 - "Tailored Treatments for Non-Segmental Vitiligo in a 38-Year-Old Male Patient" - 1 KOL in this panel
© 2024 MJH Life Sciences

All rights reserved.